We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Could Persistent CD30 Signaling Lead to Blood Cancers?

News   Apr 15, 2019 | Original story from Helmholtz Zentrum München

 
Could Persistent CD30 Signaling Lead to Blood Cancers?

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Inflammatory Bowel Disease May Be Exacerbated by High-Sugar Diet

News

A new study points to sugar - particularly the glucose found in high fructose corn syrup developed by the food industry in the 1960s and then increasingly used to sweeten soft drinks and other foods - as a prime suspect of IBD.

READ MORE

Nanobiologic Approach Trains the Innate Immune System To Eliminate Tumor Cells

News

A novel type of cancer immunotherapy trains the innate immune system to help it eliminate cancer cells through the use of nanobiologics, tiny materials bioengineered from natural molecules that are partnered with a therapeutic component.

READ MORE

How the Immune System Tackles the Bacteria in Our Gut

News

New research published in Nature suggests that the gut's local immune system can be quite precise, creating antibodies that appear to home in on specific microbiota.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE